Cargando…
Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy
Spinal muscular atrophy 5q (SMA5q) is one of the most severe and common genetic diseases. In the natural course, the disease leads to premature death (in acute forms) or severe motor disability (in chronic forms). As the genetic basis of SMA is very homogenous, the diagnostics are based entirely on...
Autor principal: | Jędrzejowska, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751307/ https://www.ncbi.nlm.nih.gov/pubmed/33364872 http://dx.doi.org/10.2147/DNND.S246907 |
Ejemplares similares
-
Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan
por: Kimizu, Tomokazu, et al.
Publicado: (2021) -
Spinal Muscular Atrophy Diagnosed by Newborn Screening
por: Lopez-Chacon, Matias, et al.
Publicado: (2019) -
Interventions for spinal muscular atrophy: an impetus for newborn screening
Publicado: (2021) -
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
por: Weidlich, Diana, et al.
Publicado: (2023) -
Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies
por: Dezfouli, Mahya, et al.
Publicado: (2020)